VPM1002 (Tuberculosis BCG Based Vaccine) for Prevent Covid-19 Market Key Drivers and Forecast 2025-2032
VPM1002 (Tuberculosis BCG Based Vaccine) for Prevent Covid-19 Market Trends And Drivers The global VPM1002 (Tuberculosis BCG Based Vaccine) for preventing Covid-19 market was valued at USD 0.13 Billion in 2022 and is projected to reach USD 1.2 Billion by 2030, growing at a CAGR of 33.9% from 2024 to 2030. The increasing interest in […]
Continue Reading